Post Marketing Surveillance on Long Term Use of JARDIANCE® Tablets in Patients with Chronic Kidney Disease in Japan

Study identification

• EU PAS number:
  EUPAS1000000279
• Study ID:
  1000000279
• Official title and acronym:
  Post Marketing Surveillance on Long Term Use of JARDIANCE® Tablets in Patients with Chronic Kidney Disease in Japan
• DARWIN EU® study:
  No
• Study countries:
  Japan
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

No information provided.

Study timelines

Date when funding contract was signed

Planned:15/08/2024

Study start date

Planned:01/09/2024

Actual:22/10/2024

Date of final study report

Planned:30/04/2028

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Nippon Boehringer Ingelheim Co., Ltd.

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  Non-EU RMP only

Other study registration identification numbers and links

1245-0340
NCT06527846